Healthcare >> Sector Roundtables >> March 8, 2004
DR. GIRISH TYAGI is a Principal in the Research Department at Thomas
Weisel Partners LLC, where he covers the Major Pharmaceuticals sector.
Previously, he was the Senior Healthcare Analyst at ABN Amro. Prior to
entering the securities business, Dr. Tyagi practiced medicine for 15
years. Dr. Tyagi received a Pre-Medical degree from Delhi University, a
Medical degree from the M.A. Medical College of New Delhi, India, and a
Master of Business Administration degree from Northeastern University in
Boston, Massachusetts. Dr. Tyagi is board certified in Internal Medicine
(United Kingdom) and Radiology (United States and United Kingdom). He is
a Member of the Royal College of Physicians of the United Kingdom and a
Fellow of the Royal College of Radiologists. Profile
DAVID MOSKOWITZ is Managing Director of the healthcare research group at
Friedman, Billings, Ramsey Group, Inc. He joined FBR in July 2001 and
currently covers the large cap pharmaceutical sector in addition to
select specialty pharmaceutical companies. From 1999 to 2001, Mr.
Moskowitz worked for UBS Warburg as a specialty pharmaceuticals analyst,
and from 1998 to 1999, he was a biotechnology analyst for Standard &
Poor's. Prior to entering the financial services industry, Mr. Moskowitz
practiced as a Registered Pharmacist in various hospital and retail
settings for nearly 10 years. Mr. Moskowitz received his BS degree in
Pharmacy from Rutgers University and his MBA degree in Finance and
Pharmaceutical Industry Studies from Fairleigh Dickinson University. Profile
last year and the second half was certainly not very good. What went on?
Mr. Verhoef: I think in the second half of the
